IDH1 and glioblastoma: However, GBM and IDH wt patients did not have statistical significance because of the large difference in sample size (Supplementary Figures S2A–D).All results agree that the mortality rate of the low-risk groups is lower than that of the high-risk groups, and the FRLS prognosis can accurately and stably predict the survival outcome of GBM/LGG patients.